32222-47-2Relevant articles and documents
COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
-
Page/Page column 34; 35, (2021/06/11)
The invention relates to a compound of Formula I, pharmaceutical compositions comprising a compound of Formula I, and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I to
PERK INHIBITING COMPOUNDS
-
Paragraph 0138-0140, (2021/03/05)
Provided herein are compounds of formula (I), compositions, and methods useful for inhibiting PERK and for treating related conditions, diseases, and disorders.
PERK INHIBITING PYRROLOPYRIMIDINE COMPOUNDS TO TREAT VIRAL INFECTIONS
-
Page/Page column 57; 58, (2021/11/20)
Provided herein are methods for treating a viral infection in a patient, comprising administering to said patient a therapeutically effective amount of a PERK inhibitor selected from a compound having the structure (I):